Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder

Scandinavian Journal of Urology and Nephrology

Volumn 45, Issue 4, 2011, Pages 251-257

  May, Matthias ^a   Bastian, Patrick J ^b   Brookman May, Sabine ^c   Burger, Maximilian ^c   Bolenz, Christian ^d   Trojan, Lutz ^d   Michel, Maurice S ^d   Herrmann, Edwin ^e   Wlfing, Christian ^e   Tiemann, Arne ^e   Mller, Stefan C ^f   Ellinger, Jörg ^f   Buchner, Alexander ^b   Stief, Christian G ^b   Tilki, Derya ^b   Wieland, Wolf F ^c   Gilfrich, Christian ^a   Höfner, Thomas ^d   Hohenfellner, Markus ^d   Haferkamp, Axel ^d,g   Roigas, Jan ^h   Zacharias, Mario ⁱ   Gunia, Sven ^j   Fritsche, Hans Martin ^c   more..

^a Urologische Klinik   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f UNIVERSITY OF BONN   (Germany)

^g GOETHE UNIVERSITY   (Germany)

^h VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

ⁱ Vivantes Klinikum AVK Berlin   (Germany)

^j HELIOS Klinikum Bad Saarow   (Germany)

more..

Author keywords

Bladder cancer; Clinical tumour stage T1; Lymphovascular invasion; Prognosis; Radical cystectomy; Upstaging; Urothelial carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TREATMENT INDICATION;

AGED; CARCINOMA; CYSTECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 80051725841     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.3109/00365599.2011.562235     Document Type: Article

References (15)

1. Kulkarni GS, Hakenberg OW, Gschwend JE, Thalmann G, Kassouf W, Kamat A, et al. An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer. Eur Urol 2010;57:60-70.
2. Dalbagni G, Kaag M, Cronin A, Vora K, Bochner B, Donat SM, et al. Variability of treatment selection among surgeons for patients with cT1 urothelial carcinoma. BJU Int 2010;106:1502-7.
3. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J, European Association of Urology (EAU). EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008;54:303-14.
4. Cookson MS, Herr HW, Zhang ZF, Soloway S, Sogani PC, Fair WR. The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 1997;158:62-7. (Pubitemid 27251595)
5. Freeman JA, Esrig D, Stein JP, Simoneau AR, Skinner EC, Chen SC, et al. Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer 1995;76:833-9.
6. Bianco FJ Jr, Justa D, Grignon DJ, Sakr WA, Pontes JE, Wood DP Jr. Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy. Urol Oncol 2004;22:290-4. (Pubitemid 38996784)
7. Gupta A, Lotan Y, Bastian PJ, Palapattu GS, Karakiewicz PI, Raj GV, et al., Bladder Cancer Research Consortium. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy. Urology 2008;71:302-7. (Pubitemid 351282384)
8. Guzzo TJ, Magheli A, Bivalacqua TJ, Nielsen ME, Attenello FJ, Schoenberg MP, et al. Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette- Guerinrefractory bladder cancer. Urology 2009;74:1276-80.
9. Fritsche HM, Burger M, Svatek RS, Jeldres C, Karakiewicz PI, Novara G, et al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 2010;57:300-9.
10. Wittekind C, Meyer HJ, Bootz F. TNM Klassifikation maligner Tumoren. 6 Auflage. Berlin: Springer; 2002.
11. Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466-5.
12. Streeper NM, Simons CM, Konety BR, Muirhead DM, Williams RD, O'Donnell MA, et al. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer. BJU Int 2009;103:475-9.
13. Cho KS, Seo HK, Joung JY, Park WS, Ro JY, Han KS, et al. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer. J Urol 2009;182:2625-30.
14. Kunju LP, You L, Zhang Y, Daignault S, Montie JE, Lee CT. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens. J Urol 2008;180:1928-32.
15. Nese N, Gupta R, Bui MH, Amin MB. Carcinoma in situ of the urinary bladder: review of clinicopathologic characteristics with an emphasis on aspects related to molecular diagnostic techniques and prognosis. J Natl Compr Canc Netw 2009;7:48-57.